- About Us
- Healthcare Companies
- Pharmacy Solutions
- Healthcare Professionals
- Contact Us
- MyAH Portal
Takeda UK Limited is recalling the below batch of Instanyl 100mcg nasal spray solution (EU/1/09/531/015) due to the observation of cracked vials during inspection of the bulk vials and release testing of the finished products. So far, the company has not received any reports of damage for the marketed products. However, due to the low potential for breaking or cracking of the glass vial, which is contained within the plastic actuator casing and a potential risk of microbial contamination, the above batch is being recalled as a precautionary measure
MHRA drug alert link: https://www.gov.uk/drug-device-alerts/company-led-medicines-recall-instanyl-100mcg-nasal-spray-solution-eu-slash-1-slash-09-slash-531-slash-015?utm_medium=email&utm_campaign=govuk-notifications&utm_source=a6ea9305-5a64-4dd6-ae86-912f9bbbe915&utm_content=immediately
INSTANYL 100MCG SINGLE DOSE
Takeda UK Limited
Alliance have not supplied this product and therefore we are not accepting stock returns.
Company Contact for medical information enquiries
For medical information enquiries, please contact: Takeda UK Limited by emailing email@example.com
Company Contact for stock enquiries
Remaining stock of these batches should be quarantined and returned to Takeda for replacement stock where available.
For stock information enquiries, please contact: Alloga UK by emailing allogaUK.firstname.lastname@example.org